Treatment Considerations of Myelodysplastic Syndromes/ Neoplasms for Pathologists

被引：0
|
作者：
Madanat, Yazan F. [1 ]
Zeidan, Amer M. [2 ]
机构：
[1] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Div Hematol & Med Oncol, Clin Med, Dallas, TX USA
[2] Yale Univ, Yale Canc Ctr, Smilow Canc Ctr, Dept Internal Med,Sect Hematol, New Haven, CT 06520 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2023年 / 43卷 / 04期
关键词：
MDS treatment; Therapeutic scheme; Approach to MDS; Genomics in MDS; WORLD-HEALTH-ORGANIZATION; PROGNOSTIC SCORING SYSTEM; ACUTE MYELOID-LEUKEMIA; LOWER-RISK MDS; PHASE-III; CLASSIFICATION; MUTATIONS; EFFICACY; LENALIDOMIDE; LUSPATERCEPT;
D O I：
10.1016/j.cll.2023.07.003
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：685 / 698
页数：14
相关论文
共 50 条
  • [1] Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms
    Charlotte K. Brierley
    David P. Steensma
    Current Hematologic Malignancy Reports, 2016, 11 : 408 - 415
  • [2] Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms
    Brierley, Charlotte K.
    Steensma, David P.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 408 - 415
  • [3] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Cazzola, Mario
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
  • [4] Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms
    Li, Yufeng
    Lin, Pei
    Ge, Yimin
    Garcia-Manero, Guillermo
    LEUKEMIA RESEARCH, 2013, 37 (04) : 463 - 464
  • [5] MOLECULAR ALTERATIONS ASSOCIATED WITH PROGRESSION OF MYELODYSPLASTIC SYNDROMES TO MYELODYSPLASTIC SYNDROMES/MYELOPROLIFERATIVE NEOPLASMS
    Valencia, A.
    Masala, E.
    Buchi, F.
    Sanna, A.
    Gozzini, A.
    Contini, E.
    Torricelli, F.
    Przychodzen, B.
    Maciejewski, J. P.
    Bosi, A.
    Santini, V.
    HAEMATOLOGICA, 2015, 100 : 54 - 54
  • [6] Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms
    Zeidan, Amer M.
    Perepezko, Kate
    Salimi, Tehseen
    Washington, Terri
    Epstein, Robert S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [7] Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
    Xie, Wei
    Chen, Zhining
    Wang, So A.
    Hu, Shimin
    Li, Shaoying
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Tang, Guiling
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2993 - 3001
  • [8] The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms
    Ragon, Brittany Knick
    Savona, Michael R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S37 - S42
  • [9] Epidemiology of myeloproliferative neoplasms and myelodysplastic syndromes in Germany
    Kraywinkel, Klaus
    ONKOLOGE, 2019, 25 (11): : 948 - 956
  • [10] Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms
    Chen, Xueyan
    Johansson, Ulrika
    Cherian, Sindhu
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 521 - 547
12345